<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ecna</journal-id><journal-title-group><journal-title xml:lang="ru">Экономика науки</journal-title><trans-title-group xml:lang="en"><trans-title>Economics of Science</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-132X</issn><issn pub-type="epub">2949-4680</issn><publisher><publisher-name>Delo Publishing house</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22394/2410-132X-2017-3-2-74-88</article-id><article-id custom-type="elpub" pub-id-type="custom">ecna-88</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Фокус проблемы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Focus of the problem</subject></subj-group></article-categories><title-group><article-title>АНАЛИЗ ПРОБЛЕМ РЕАЛИЗАЦИИ ПРИОРИТЕТНОГО НАПРАВЛЕНИЯ «ПЕРСОНАЛИЗИРОВАННАЯ МЕДИЦИНА» В ФОРМАТЕ ПРОЕКТА ПОЛНОГО ЦИКЛА</article-title><trans-title-group xml:lang="en"><trans-title>ANALYSIS OF PROBLEMS OF IMPLEMENTATION OF THE PRIORITY DIRECTION OF «PERSONALIZED MEDICINE» IN THE FORMAT OF FULL PROJECT CYCLE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петров</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат химических наук, генеральный директор.</p><p>Москва.</p></bio><email xlink:type="simple">petrov@fcntp.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куракова</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurakova</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор биологических наук, директор.</p><p>Москва.</p></bio><email xlink:type="simple">idmz@mednet.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сон</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Son</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, заместитель директора по научной работе.</p><p>Москва.</p></bio><email xlink:type="simple">son@mednet.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Дирекция НТП» Минобрнауки России.</institution></aff><aff xml:lang="en"><institution>Directorate of State Scientific and Technical Programmes.</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Центр научно-технической экспертизы ИПЭИ РАНХиГС при Президенте РФ.</institution></aff><aff xml:lang="en"><institution>The Russian Presidential Academy of National Economy and Public Administration.</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ «ЦНИИОИЗ» Минздрава России.</institution></aff><aff xml:lang="en"><institution>Federal Research Institute for Health Organization and Informatics of Ministry of Health Development of the Russian Federation.</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>08</day><month>08</month><year>2017</year></pub-date><volume>3</volume><issue>2</issue><fpage>74</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Петров А.Н., Куракова Н.Г., Сон И.М., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Петров А.Н., Куракова Н.Г., Сон И.М.</copyright-holder><copyright-holder xml:lang="en">Petrov A.N., Kurakova N.G., Son I.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ecna.elpub.ru/jour/article/view/88">https://ecna.elpub.ru/jour/article/view/88</self-uri><abstract><p>На примере приоритетного направления «персонализированная медицина», выделенного Стратегией научно-технологического развития Российской Федерации, рассмотрены риски и барьеры реализации проектов полного цикла. Предложены подходы к проектированию и экспертизе комплексных научно-технологических проектов и к системе их аналитического обеспечения. Обоснована важность определения квалифицированного заказчика проектов полного цикла, в качестве которого может выступить либо ФОИВ, либо крупная компания, заинтересованная в развитии приоритетного направления. Рекомендовано делегировать квалифицированному заказчику полномочия по формированию архитектуры проектов полного цикла. Для минимизации и управления широким набором рисков и барьеров, создающих угрозу для реализации всех этапов таких проектов, необходимо проведение многопараметричной экспертизы, в рамках которой, наряду с анализом трендов развития нового технологического направления должна быть выполнена оценка экономической целесообразности, кадрового и инфраструктурного обеспечения, достаточности нормативно-правового регулирования.</p></abstract><trans-abstract xml:lang="en"><p>On an example of a priority direction «the personalized medicine», allocated by Strategy of scientific and technological development of the Russian Federation, risks and barriers of realization of projects of a full cycle are examined. Approaches to design and examination of complex scientific and technological projects and to the system of their analytical support are offered. The importance of identifying a qualified customer for full-cycle projects, in the capacity of which either the FEI or a large company interested in developing the priority direction can act, has been substantiated. It was recommended to delegate to a qualified customer the authority to formulate a full cycle project architecture. To minimize and manage a wide range of risks and barriers, that pose a threat to the implementation of all phases of such projects, a multi-parameter expertise is needed, along with an analysis of the trends in the development of a new technology direction, an assessment of economic feasibility, personnel and infrastructure support, adequacy of legal regulation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>приоритеты научно-технологического развития</kwd><kwd>реализация</kwd><kwd>проекты полного цикла</kwd><kwd>проектирование</kwd><kwd>экспертиза</kwd><kwd>персонализированная медицина</kwd></kwd-group><kwd-group xml:lang="en"><kwd>priorities of scientific and technological development</kwd><kwd>implementation</kwd><kwd>full-cycle projects</kwd><kwd>project planning</kwd><kwd>expertise</kwd><kwd>personalized medicine</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Указ Президента РФ от 1 декабря 2016 г. № 642 (2016) О Стратегии научно-техноло-гического развития Российской Федерации / Грант. http://www.garant.ru/products/ipo/prime/doc/71451998.</mixed-citation><mixed-citation xml:lang="en">Statutory Order of The President of Russian Federation dated 1 December 2016 № 642 (2016) About Strategy pf scientific and technical development of Russian Federation / Garant. http://www.garant.ru/products/ipo/prime/doc/71451998.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Горбатова А. (2017) Наука и экономика: как построить двустороннюю магистраль / Портал Наука и технологии РФ. 08.02.2017. http://www.strf.ru/material.aspx? CatalogId=221&amp;d_no=126275#.WVu0_8u7p9A.</mixed-citation><mixed-citation xml:lang="en">Gorbatova А. (2017) Science and economics: how to build a two-way main line / STRF. 08.02.2017. http://www.strf.ru/material.aspx? CatalogId=221&amp;d_no=126275#.WVu0_8u7p9A.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Распоряжение Правительства РФ от 28 декабря 2012 г. № 2580-р (2012) Стратегия развития медицинской науки в Российской Федерации на период до 2025 года / Минздрав России. https://www.rosminzdrav.ru/documents/5413-rasporyazhenie-pravitelstva-rossiyskoy-federatsiiot‑28-dekabrya‑2012-g-n‑2580-r.</mixed-citation><mixed-citation xml:lang="en">Executive Order of the Russian Government dated 28 December 2012 № 2580-r (2012) The strategy of the development of medical science in the Russian Federation for the period till 2025/ Ministry of Health of the Russian Federation. https://www.rosminzdrav.ru/documents/5413-rasporyazhenie-pravitelstva-rossiyskoy-federatsii-ot‑28-dekabrya‑2012-g-n‑2580-r.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">План мероприятий («дорожная карта») «Хелснет» Национальной технологической инициативы (2017) / НТИ. http://www.nti2035.ru/markets/docs/DK_healthnet.pdf.</mixed-citation><mixed-citation xml:lang="en">Action plan («roadmap») «HealthNet» of the National Technology Initiative (2017) / NTI. http://www.nti2035.ru/markets/docs/DK_healthnet.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Перечень поручений по итогам заседания Координационного совета по реализации Национальной стратегии действий в интересах детей от 17 февраля 2017 г. (2017) / Официальный сайт Правительства России. http://www.kremlin.ru/acts/assignments/orders/53899.</mixed-citation><mixed-citation xml:lang="en">The list of assignments on the results of the meeting of the Coordinating Council for the implementation of the National Strategy for Children's Action dated 17 February 2017 (2017) / Official website of the Russian Government. http://www.kremlin.ru/acts/assignments/orders/53899.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Путин поручил рассмотреть вопрос о расширении программы неонатального скрининга (2017) / Единая Россия. http://www.qwas.ru/russia/edinros/Putin-poruchil-rassmotret-vopros-orasshirenii-programmy-neonatalnogo-skrininga.</mixed-citation><mixed-citation xml:lang="en">Putin instructed to consider the expansion of the neonatal screening program (2017) / Edinaya Rossiya. http://www.qwas.ru/russia/edinros/Putinporuchil-rassmotret-vopros-o-rasshirenii-programmy-neonatalnogo-skrininga.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Прогноз научно-технологического развития Российской Федерации на период до 2030 года от 3 января 2014 г. (2014) / Гарант. http://www.garant.ru/products/ipo/prime/doc/70484380/#ixzz4llLAylUd.</mixed-citation><mixed-citation xml:lang="en">Forecast of scientific and technological development of the Russian Federation for the period till 2030 dated 3 January 2014 (2014) / Garant. http://www.garant.ru/products/ipo/prime/doc/70484380/#ixzz4llLAylUd.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Стратегическая программа исследований технологической платформы «Медицина будущего» (2014) / Технологическая платформа «Медицина будущего». http://libed.ru/knigi-nauka/818944–1-utverzhdayu-predsedatel-tehnologicheskoypl a t f o r m i - m e d i c i n a - b u d u s c h e g o ‑ 2 0 1 4 -strategicheskaya-programma-issledovaniy.php.</mixed-citation><mixed-citation xml:lang="en">Strategic research agenda of the Technological platform «Medicine of the future» (2014) / Technological platform «Medicine of the future». http://libed.ru/knigi-nauka/818944–1-utverzhdayupredsedatel-tehnologicheskoy-platformi-medicinabuduschego‑2014-strategicheskaya-programmaissledovaniy.php.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Публичный аналитический доклад по научно-технологическому направлению «Биомедицина» (2015) / Минздрав России. https://reestr.extech.ru/docs/analytic/reports/medicine.pdf.</mixed-citation><mixed-citation xml:lang="en">Public analytical report on science and technology direction «Biomedicine» (2015) / Ministry of Health of the Russian Federation. https://reestr.extech.ru/docs/analytic/reports/medicine.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">The Precision Medicine Initiative Cohort Program – Building a Research Foundation for 21st Century Medicine Precision Medicine (2015) / NIH. 17.09.2015. https://www.nih.gov/sites/default/files/research-training/initiatives/pmi/09172015-pmi-working-group-report.pdf.</mixed-citation><mixed-citation xml:lang="en">The Precision Medicine Initiative Cohort Program – Building a Research Foundation for 21st Century Medicine Precision Medicine (2015) / NIH. 17.09.2015. https://www.nih.gov/sites/default/files/research-training/initiatives/pmi/09172015-pmi-working-group-report.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Genomic medicine France 2025 (2015) / National Alliance for Life and Heath Sciences. http://solidarites-sante.gouv.fr/IMG/pdf/genomic_medicine_france_2025.pdf.</mixed-citation><mixed-citation xml:lang="en">Genomic medicine France 2025 (2015) / National Alliance for Life and Heath Sciences. http://solidarites-sante.gouv.fr/IMG/pdf/genomic_medicine_france_2025.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">The 100,000 Genomes Project (2017) / Genomes Project. https://www.genomicsengland.co.uk/the‑100000-genomes-project.</mixed-citation><mixed-citation xml:lang="en">The 100,000 Genomes Project (2017) / Genomes Project. https://www.genomicsengland.co.uk/the‑100000-genomes-project.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Резник И. (2017) Редкие болезни остаются редкими до тех пор, пока они малоизвестны / Медпортал. 28.02.2017. http://medportal.ru/mednovosti/news/2017/02/27/339raredisease.</mixed-citation><mixed-citation xml:lang="en">Reznik I. (2017) Rare diseases are rare as long as they are not well known / Medportal. 28.02.2017. http://medportal.ru/mednovosti/news/2017/02/27/339raredisease.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Павлова А. (2017) Как выжить редким людям. Лечение орфанных больных требует огромных средств / Аргументы и факты. 17.06.2017. http://www.aif.ru/health/life/kak_vyzhit_redkim_lyudyam_lechenie_orfannyh_bolnyh_trebuet_ogromnyh_sredstv.</mixed-citation><mixed-citation xml:lang="en">Pavlova А. (2017) How to survive rare people. Treatment of orphan patients requires a lot of money/ Ai F. 17.06.2017. http://www.aif.ru/health/life/kak_vyzhit_redkim_lyudyam_lechenie_orfannyh_bolnyh_trebuet_ogromnyh_sredstv.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Для генетической диагностики нужна законодательная база (2017) / Портал Медицинская наука. 26.06.2017. http://medical-science.ru/?p=10694.</mixed-citation><mixed-citation xml:lang="en">For genetic diagnosis we need a legislative framework (2017) / Portal Medicine science. 26.06.2017. http://medical-science.ru/?p=10694.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Пичугина Е. (2017) Генетики помогут женщинам рожать только здоровых детей / Московский комсомолец. 07.04.2017. http://www.mk.ru/science/2017/04/07/genetiki-pomogutzhenshhinam-rozhat-tolko-zdorovykh-detey.html.</mixed-citation><mixed-citation xml:lang="en">Pichugina Е. (2017) Genetics will help women to give birth only to healthy children/ Moskovskij komsomolec. 07.04.2017. http://www.mk.ru/science/2017/04/07/genetiki-pomogut-zhenshhinamrozhat-tolko-zdorovykh-detey.html.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Для исследований соберут генетическую информацию 1 млн. человек (2017) / Медицинская энциклопедия TeamHelp. http://teamhelp.ru/novosti/dlya-issledovanij-soberut-geneticheskuyuinformatsiyu‑1-mln-chelovek.html.</mixed-citation><mixed-citation xml:lang="en">The genetic data from 1 million people will be collected for research (2017) / Medical Encyclopedia TeamHelp. http://teamhelp.ru/novosti/dlya-issledovanij-soberut-geneticheskuyu-informatsiyu‑1-mlnchelovek.html.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mullin Е. (2017) The World’s Most Expensive Medicine Is Being Pulled from the Market // MIT technology review. 21.04.2017. https://www.technologyreview.com/s/604252/the-worldsmost-expensive-medicine-is-being-pulled-from-themarket.</mixed-citation><mixed-citation xml:lang="en">Mullin Е. (2017) The World’s Most Expensive Medicine Is Being Pulled from the Market // MIT technology review. 21.04.2017. https://www.technologyreview.com/s/604252/the-worlds-most-expensive-medicine-is-being-pulled-from-the-market.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Кудрявцева Е. (2015) Угол внутригенно / Коммерсант. 27.04.2015. https://www.kommersant.ru/doc/2713110.</mixed-citation><mixed-citation xml:lang="en">Kudryavtseva Е. (2015) Injection intragenous / Kommersant. 27.04.2015. https://www.kommersant.ru/doc/2713110.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Мусиенко С. (2016) Пока неточная медицина / Ведомости. 07.12.2016. https://www.vedomosti.ru/opinion/articles/2016/12/07/668500-netochnaya-meditsina.</mixed-citation><mixed-citation xml:lang="en">Musienko S. (2016) Still imprecise medicine / Vedomosti. 07.12.2016. https://www.vedomosti.ru/opinion/articles/2016/12/07/668500-netochnayameditsina.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Горина М., Коталевская Ю. (2013) К генетику пациента должен направить участковый врач или узкий специалист, и вот это происходит не всегда, когда следует / Портал «Большой город». 08.02.2013. http://bg.ru/health/julija_kotalevskaja_k_genetiku_patsienta_dolzhen_n‑17054.</mixed-citation><mixed-citation xml:lang="en">Gorina М., Kotalevskaya U. (2013) To genetics the patient should be guide by the district physician or a specialist, and this does not always happen when it should be done / Portal «Bolshoi gorod». 08.02.2013. http://bg.ru/health/julija_kotalevskaja_k_genetiku_patsienta_dolzhen_n‑17054.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Покровский А. Г. (2015) Мозговой штурм. Персонализированная медицина – стенограмма выступления. http://forumtechnoprom.com/data/files/1.</mixed-citation><mixed-citation xml:lang="en">Pokrovsky А.G. (2015) Brainstorm. Personalized medicine – the transcript of the speech. http://forumtechnoprom.com/data/files/1.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Минздрав США призвал разрешить скрещивание клеток человека и животных (2016) / Православие и мир. 08.08.2016. http://www.pravmir.ru/minzdrav-ssha-prizval-razreshit-skreshhivanie-kletokcheloveka-i-zhivotnyih.</mixed-citation><mixed-citation xml:lang="en">The US Ministry of Health called for permission to cross human and animal cells (2016) / Orthodoxy and Peace. 08.08.2016. http://www.pravmir.ru/minzdrav-ssha-prizval-razreshit-skreshhivanie-kletokcheloveka-i-zhivotnyih.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Филипенко М. (2015) Мозговой штурм. Персонализированная медицина – стенограмма выступления. http://forumtechnoprom.com/data/files/1.</mixed-citation><mixed-citation xml:lang="en">Filippenko М. (2015) Brainstorm. Personalized medicine – the transcript of the speech. http://forumtechnoprom.com/data/files/1.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Zi Tan Y. et al. (2017) Addressing preferred specimen orientation in single-particle cryo-EM through tilting // Nature. 03.07.2017. ttps://www.nature.com/nmeth/journal/vaop/ncurrent/full/nmeth.4347.html.</mixed-citation><mixed-citation xml:lang="en">Zi Tan Y. et al. (2017) Addressing preferred specimen orientation in single-particle cryo-EM through tilting // Nature. 03.07.2017. ttps://www.nature.com/nmeth/journal/vaop/ncurrent/full/nmeth.4347.html.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Jason L. Vassy et al. (2017) The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial // Annals of Internal Medicine. 27.06.2017. http://annals.org/aim/article/2633848/impact-whole-genome-sequencingprimary-care-outcomes-healthy-adult-patients.</mixed-citation><mixed-citation xml:lang="en">Jason L. Vassy et al. (2017) The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial // Annals of Internal Medicine. 27.06.2017. http://annals.org/aim/article/2633848/impactwhole-genome-sequencing-primary-care-outcomeshealthy-adult-patients.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Бескаравайная Т. (2017) Паоло Маккиарини лишили финансирования в России / Медвестник. 17.05.2017. https://www.medvestnik.ru/content/news/Paolo-Makkiarini-lishili-finansirovaniya-v-Rossii.html.</mixed-citation><mixed-citation xml:lang="en">Beskaravainaya Т. (2017) Paolo Macchiarini was deprived of funding in Russia/ Medvestnik. 17.05.2017. https://www.medvestnik.ru/content/news/Paolo-Makkiarini-lishili-finansirovaniya-v-Rossii.html.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
